FUS (“Fused in sarcoma”) was initially identified as part of a chromosomal translocation in human liposarcomas where the FUS gene is fused to the gene CHOP, whereby the RNA-binding domains of FUS are replaced by the basic leucine zipper domain of CHOP [172]. The gene discussed is DDIT3; the disease is sarcoma.